Literature DB >> 11071910

Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression.

A Dey1, H She, L Kim, A Boruch, D L Guris, K Carlberg, S M Sebti, D T Woodley, A Imamoto, W Li.   

Abstract

Colony-stimulating factor-1 (CSF-1) induces expression of immediate early gene, such as c-myc and c-fos and delayed early genes such as D-type cyclins (D1 and D2), whose products play essential roles in the G1 to S phase transition of the cell cycle. Little is known, however, about the cytoplasmic signal transduction pathways that connect the surface CSF-1 receptor to these genes in the nucleus. We have investigated the signaling mechanism of CSF-1-induced D2 expression. Analyses of CSF-1 receptor autophosphorylation mutants show that, although certain individual mutation has a partial inhibitory effect, only multiple combined mutations completely block induction of D2 in response to CSF-1. We report that at least three parallel pathways, the Src pathway, the MAPK/ERK kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway, and the c-myc pathway, are involved. Induction of D2 is partially inhibited in Src(-/-) bone marrow-derived macrophages and by Src inhibitor PP1 and is enhanced in v-Src-overexpressing cells. Activation of myc's transactivating activity selectively induces D2 but not D1. Blockade of c-myc expression partially blocks CSF-1-induced D2 expression. Complete inhibition of the MEK/ERK pathway causes 50% decrease of D2 expression. Finally, simultaneous inhibition of Src, MEK activation, and c-myc expression additively blocks CSF-1-induced D2 expression. This study indicates that multiple signaling pathways are involved in full induction of a single gene, and this finding may also apply broadly to other growth factor-inducible genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11071910      PMCID: PMC15040          DOI: 10.1091/mbc.11.11.3835

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  52 in total

1.  p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity.

Authors:  M N Lioubin; P A Algate; S Tsai; K Carlberg; A Aebersold; L R Rohrschneider
Journal:  Genes Dev       Date:  1996-05-01       Impact factor: 11.361

Review 2.  Protein modules and signalling networks.

Authors:  T Pawson
Journal:  Nature       Date:  1995-02-16       Impact factor: 49.962

3.  Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes.

Authors:  E C Lerner; Y Qian; M A Blaskovich; R D Fossum; A Vogt; J Sun; A D Cox; C J Der; A D Hamilton; S M Sebti
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

4.  Interactions of phosphatidylinositol kinase, GTPase-activating protein (GAP), and GAP-associated proteins with the colony-stimulating factor 1 receptor.

Authors:  M Reedijk; X Q Liu; T Pawson
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

Review 5.  Regulation of cell cycle entry and G1 progression by CSF-1.

Authors:  M F Roussel
Journal:  Mol Reprod Dev       Date:  1997-01       Impact factor: 2.609

6.  Tyrosine phosphorylation of a common 57-kDa protein in growth factor-stimulated and -transformed cells.

Authors:  W Li; Y G Yeung; E R Stanley
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

7.  Uncoupling of the proliferation and differentiation signals mediated by the murine macrophage colony-stimulating factor receptor expressed in myeloid FDC-P1 cells.

Authors:  R P Bourette; G M Myles; K Carlberg; A R Chen; L R Rohrschneider
Journal:  Cell Growth Differ       Date:  1995-06

8.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Authors:  D E Quelle; R A Ashmun; S A Shurtleff; J Y Kato; D Bar-Sagi; M F Roussel; C J Sherr
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

9.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.

Authors:  T D Littlewood; D C Hancock; P S Danielian; M G Parker; G I Evan
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

10.  Shc, Grb2, Sos1, and a 150-kilodalton tyrosine-phosphorylated protein form complexes with Fms in hematopoietic cells.

Authors:  M N Lioubin; G M Myles; K Carlberg; D Bowtell; L R Rohrschneider
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

View more
  24 in total

1.  Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.

Authors:  C Bouchard; O Dittrich; A Kiermaier; K Dohmann; A Menkel; M Eilers; B Lüscher
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

2.  Segment- and cell-specific expression of D-type cyclins in the postnatal mouse epididymis.

Authors:  Huizhen Wang; T Rajendra Kumar
Journal:  Gene Expr Patterns       Date:  2012-01-24       Impact factor: 1.224

3.  ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets.

Authors:  Jessie Villanueva; Yuval Yung; Janice L Walker; Richard K Assoian
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

Review 4.  Src signaling pathways in prostate cancer.

Authors:  Andreas Varkaris; Anastasia D Katsiampoura; John C Araujo; Gary E Gallick; Paul G Corn
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

5.  Perlecan is required for FGF-2 signaling in the neural stem cell niche.

Authors:  Aurelien Kerever; Frederic Mercier; Risa Nonaka; Susana de Vega; Yuka Oda; Bernard Zalc; Yohei Okada; Nobutaka Hattori; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  Stem Cell Res       Date:  2013-12-28       Impact factor: 2.020

6.  Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays.

Authors:  Rolf I Skotheim; Vera M Abeler; Jahn M Nesland; Sophie D Fosså; Ruth Holm; Urs Wagner; Vivi Ann Flørenes; Nina Aass; Olli P Kallioniemi; Ragnhild A Lothe
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

7.  Vasopressin up-regulates the expression of growth-related immediate-early genes via two distinct EGF receptor transactivation pathways.

Authors:  Lida Q Fuentes; Carlos E Reyes; José M Sarmiento; Carolina I Villanueva; Carlos D Figueroa; Javier Navarro; Carlos B González
Journal:  Cell Signal       Date:  2008-05-25       Impact factor: 4.315

8.  A phase I trial of dasatinib, an SRC-family kinase inhibitor, in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancer.

Authors:  Angeles Alvarez Secord; Deanna K Teoh; William T Barry; Miao Yu; Gloria Broadwater; Laura J Havrilesky; Paula S Lee; Andrew Berchuck; Johnathan Lancaster; Robert M Wenham
Journal:  Clin Cancer Res       Date:  2012-07-26       Impact factor: 12.531

9.  Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage.

Authors:  Umesh Sharma; Nour-Eddine Rhaleb; Saraswati Pokharel; Pamela Harding; Saman Rasoul; Hongmei Peng; Oscar A Carretero
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-04       Impact factor: 4.733

10.  Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation.

Authors:  Eric Masy; Eric Adriaenssens; Claire Montpellier; Pascale Crépieux; Alexandra Mougel; Brigitte Quatannens; Gautier Goormachtigh; Nathalie Faumont; Fabienne Meggetto; Claude Auriault; Hervé Groux; Jean Coll
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.